Results 211 to 220 of about 86,450 (250)

MULTIPLE DRUG–RESISTANT TUBERCULOSIS

Infectious Disease Clinics of North America, 1998
The national and international emergence of drug-resistant M. tuberculosis has complicated both the programmatic control of the tuberculosis epidemic and the clinical management of individual cases. In the United States, the problem of MDR tuberculosis is regionalized and likely stems from multifactorial causes, including the concurrent HIV epidemic ...
W Z, Bradford, C L, Daley
openaire   +2 more sources

Drug-Resistant Tuberculosis in Pediatrics

Pediatric Clinics of North America, 1995
As the incidence of tuberculosis in the United States has increased over the past 10 years, the number of cases caused by drug-resistant organisms has risen dramatically. The genetic mechanisms of resistance, which could lead to better methods of diagnosis and treatment, are being determined.
D S, Swanson, J R, Starke
openaire   +2 more sources

A tuberculosis drug-resistance register

Tubercle, 1961
Summary A register of 287 patients from whom bacilli resistant to the anti-tuberculosis drugs have been isolated, has been kept for the City of Birmingham from 1956–1959. An annual fall of 40% in patients newly found to be excreting these bacilli has been demonstrated.
openaire   +2 more sources

Transitional drug-resistance in tuberculosis

Tubercle, 1971
Abstract The sensitivity test results during chemotherapy were studied of 468 patients with initially sensitive cultures. In all but 2 cases no resistant cultures were isolated. In 2 cases the final positive culture was resistant to isoniazid. One died and the other had no more positive cultures after a change of treatment.
openaire   +2 more sources

Control of drug-resistant tuberculosis

Tubercle and Lung Disease, 1995
Drug-resistant tuberculosis is a global problem, but the necessity and quality of intervention should be assessed by country since the causes of drug resistance, and thus the appropriate intervention strategies, may vary considerably between countries.
C S, Lambregts-van Weezenbeek, J, Veen
openaire   +2 more sources

Multiple-Drug-Resistant Tuberculosis

Clinical Infectious Diseases, 1994
The modern era of tuberculosis recently has been characterized by a rise in the number of cases of infection with multiple-drug-resistant (MDR) Mycobacterium tuberculosis. This acquisition of resistance to various established antituberculosis drugs has compromised both treatment and control programs worldwide.
openaire   +2 more sources

Drug resistant tuberculosis and HIV

Nursing Standard, 1990
High frequencies of drug resistant tuberculosis in people who are HIV positive are reported from America.
openaire   +2 more sources

Epidemiology of Drug-Resistant Tuberculosis

2017
As we move into the era of the Sustainable Development Goals (SDGs), the World Health Organization (WHO) has developed the End TB strategy 2016-2035 with a goal to end the global epidemic of tuberculosis (TB) by 2035. Achieving the targets laid out in the Strategy will require strengthening of the whole TB diagnosis and treatment cascade, including ...
Anna S, Dean, Helen, Cox, Matteo, Zignol
openaire   +2 more sources

Drug-Resistant Tuberculosis

American Review of Respiratory Disease, 1991
D E, Snider, G M, Cauthen, L S, Farer, G D, Kelly, J O, Kilburn, R C, Good, S W, Dooley   +6 more
openaire   +2 more sources

Drug‐Resistant Tuberculosis in Africa

Annals of the New York Academy of Sciences, 2001
Abstract: Africa has the highest incidence rate per capita of tuberculosis, although the rate varies among the African countries from 17.8% in Cameroon to 70% in Botswana, Zambia, and Zimbabwe. Nevertheless, the levels of drug resistance are relatively low, compared to countries like Russia and Estonia.
openaire   +2 more sources